Eric Lefkofsky is the Chicago-based founder of Tempus. Tempus was founded in 2015 in Chicago and has offices in several other states. With 2000 employees and worth over eight billion dollars, Eric Lefkofsky’s company is still growing. Most of the company’s revenue comes from lab testing. Tempus started by providing medical lab testing and conducting research for cancer and depression. Over the years, they have expanded their scope of work by providing COVID19 testing as well as testing for diabetes, heart problems, and other diseases.

Not only is Tempus provide testing for COVID19, but the company is conducting COVID research as well, making their work an integral resource to combat the current pandemic. Tempus has created a portable device for doctors that allows them to access the company’s expansive database of genetic information and resources. It uses a microphone to let doctors ask questions hands-free. This device combines artificial intelligence with an intuitive database so doctors can serve patients more effectively and get the information they need faster. One of the services that Tempus offers is clinical trial matching. This allows patients to get matched with research projects that would fit their needs and conditions based on their genetic makeup and the medications they have been prescribed.